Literature DB >> 18501644

Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice.

G M Campo1, A Avenoso, S Campo, A D'Ascola, P Traina, A Calatroni.   

Abstract

OBJECTIVE: Free radical damage, inflammation, and apoptosis play a critical role in the onset and progression of cartilage erosion in arthritis. Many studies have demonstrated that glycosaminoglycans (GAGs), and chondroitin-4-sulphate (C4S) in particular, possess antioxidant activity that is able to inhibit lipid peroxidation which is the main mechanism of free radical-mediated biological injury. In addition to the effect directly exerted by reactive oxygen species (ROS), the activation of nuclear factor kB (NF-kB) and caspases may contribute substantially to increase inflammation and cell damage. We studied whether the antioxidant action of chronic C4S treatment to reduce ROS injury involves NF-kB and caspases modulation using an experimental model of collagen-induced arthritis in mice.
METHODS: Arthritis was induced in mice via an intradermal injection at the base of the tail of 100 microl of emulsion containing bovine type II collagen in complete Freund's adjuvant.
RESULTS: Arthritis provoked the following: severe oedema and inflammation in the hind paws; lipid peroxidation in the joints [measured by 8-isoprostane (8-IPE) levels]; reduction of the endogenous antioxidants catalase (CAT) activity and reduced glutathione (GSH) levels; induction of NF-kB translocation; a loss of cytoplasmic NF-kB inhibitor alpha (IkBalpha); an increase in metalloproteinase-13 (MMP-13), caspase-3 and caspase-7 gene expression and their related protein; the induction of cartilage polymorphonuclear (PMN) activation and infiltration [evaluated by elastase (ELA) assay] and cartilage alterations evaluated by histological analysis. Intraperitoneal administration of different doses of C4S (for 25 days), ameliorated all the symptoms of inflammation in the articular knee and paw joints, limited lipid peroxidation, inhibited NF-kB activation and IkBalpha protein loss, decreased mRNA MMP-13 and caspases expression and their related protein, restored endogenous antioxidants, and reduced PMN accumulation in the damaged cartilage.
CONCLUSION: The evidence that C4S was able to inhibit NF-kB and apoptosis activation supports the hypothesis that the C4S effect depends on reduction of ROS production, although other direct effects cannot be excluded.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501644     DOI: 10.1016/j.joca.2008.04.002

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  11 in total

1.  * CRISPR-Based Epigenome Editing of Cytokine Receptors for the Promotion of Cell Survival and Tissue Deposition in Inflammatory Environments.

Authors:  Niloofar Farhang; Jonathan M Brunger; Joshua D Stover; Pratiksha I Thakore; Brandon Lawrence; Farshid Guilak; Charles A Gersbach; Lori A Setton; Robby D Bowles
Journal:  Tissue Eng Part A       Date:  2017-02-28       Impact factor: 3.845

Review 2.  Chondroitin and glucosamine in the management of osteoarthritis: an update.

Authors:  Yves Henrotin; Cécile Lambert
Journal:  Curr Rheumatol Rep       Date:  2013-10       Impact factor: 4.592

3.  Identification of specific chondroitin sulfate species in cutaneous autoimmune disease.

Authors:  Jessica S Kim; Victoria P Werth
Journal:  J Histochem Cytochem       Date:  2011-08       Impact factor: 2.479

4.  Chondroitin sulfate in the treatment of osteoarthritis: from in vitro studies to clinical recommendations.

Authors:  Yves Henrotin; Mariane Mathy; Christelle Sanchez; Cecile Lambert
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-12       Impact factor: 5.346

Review 5.  Drug Screening Implicates Chondroitin Sulfate as a Potential Longevity Pill.

Authors:  Collin Y Ewald
Journal:  Front Aging       Date:  2021-09-08

Review 6.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

7.  Ultraviolet irradiation induces the accumulation of chondroitin sulfate, but not other glycosaminoglycans, in human skin.

Authors:  Benjamin Boegel Werth; Muhammad Bashir; Laura Chang; Victoria P Werth
Journal:  PLoS One       Date:  2011-08-04       Impact factor: 3.240

8.  New Frontiers for Cartilage Repair and Protection.

Authors:  Kenneth Zaslav; Timothy McAdams; Jason Scopp; Jason Theosadakis; Vivek Mahajan; Alberto Gobbi
Journal:  Cartilage       Date:  2012-01       Impact factor: 4.634

9.  Systematic Analysis of Pharmaceutical Preparations of Chondroitin Sulfate Combined with Glucosamine.

Authors:  Gustavo R C Santos; Adriana A Piquet; Bianca F Glauser; Ana M F Tovar; Mariana S Pereira; Eduardo Vilanova; Paulo A S Mourão
Journal:  Pharmaceuticals (Basel)       Date:  2017-04-01

Review 10.  Glycosaminoglycan-based biomaterials for growth factor and cytokine delivery: Making the right choices.

Authors:  Daniel Hachim; Thomas E Whittaker; Hyemin Kim; Molly M Stevens
Journal:  J Control Release       Date:  2019-10-16       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.